An Integrative Computational Approach to Evaluate Genetic Markers for Chronic Lymphocytic Leukemia

Recent studies reported hundreds of genes linked to chronic lymphocytic leukemia (CLL). However, many of these candidate genes were lack of replication and results were not always consistent. Here, we proposed a computational workflow to curate and evaluate CLL-related genes. The method integrates large-scale literature knowledge data, gene expression data, and related pathways/network information for quantitative marker evaluation. Pathway Enrichment, Sub-Network Enrichment, and Gene-Gene Interaction analysis were conducted to study the pathogenic profile of the candidate genes, with four metrics proposed and validated for each gene. By using our approach, a scalable CLL genetic database was developed including CLL-related genes, pathways, diseases and information of supporting references. The CLL case/control classification supported the effectiveness of the four proposed metrics, which successfully identified nine well-studied CLL genes (i.e., TNF, BCL2, TP53, VEGFA, P2RX7, AKT1, SYK, IL4, and MDM2) and highlighted two newly reported CLL genes (i.e., PDGFRA and CSF1R). The computational biology approach and the CLL database developed in this study provide a valuable resource that may facilitate the understanding of the genetic profile of CLL.

[1]  Anton Yuryev,et al.  Extracting human protein interactions from MEDLINE using a full-sentence parser , 2004, Bioinform..

[2]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[3]  Andrew S Duncombe,et al.  Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia. , 2012, Blood.

[4]  John N Weinstein,et al.  A curated census of autophagy-modulating proteins and small molecules , 2014, Autophagy.

[5]  Marc K Hellerstein,et al.  In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. , 2005, The Journal of clinical investigation.

[6]  Steve Rosen,et al.  Estrogen receptor analysis in chronic lymphocytic leukemia , 1983 .

[7]  C. Fegan,et al.  NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia. , 2009, Future oncology.

[8]  Richard P. Junghans,et al.  Cell Density Plays a Critical Role in Ex Vivo Expansion of T Cells for Adoptive Immunotherapy , 2010, Journal of biomedicine & biotechnology.

[9]  Sandra Siegel,et al.  Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia12 , 2008, The Journal of Immunology.

[10]  M. Davids,et al.  Phosphoinositide 3'-kinase inhibition in chronic lymphocytic leukemia. , 2013, Hematology/oncology clinics of North America.

[11]  Hongbao Cao,et al.  Three dysconnectivity patterns in treatment-resistant schizophrenia patients and their unaffected siblings , 2015, NeuroImage: Clinical.

[12]  Christian Billard,et al.  Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. , 2004, Leukemia research.

[13]  Gabriel Pons,et al.  Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. , 2006, Experimental hematology.

[14]  A. Österborg,et al.  The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells , 2013, PloS one.

[15]  Richard Sherry,et al.  The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. , 2011, Blood.

[16]  B. Espinet,et al.  Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go , 2014, BioMed research international.

[17]  Anton Yuryev,et al.  Molecular Networks in microarray Analysis , 2007, J. Bioinform. Comput. Biol..

[18]  Mohammed Shanshal,et al.  Chronic lymphocytic leukemia. , 2012, Disease-a-month : DM.

[19]  M. Belosevic,et al.  Teleost soluble CSF-1R modulates cytokine profiles at an inflammatory site, and inhibits neutrophil chemotaxis, phagocytosis, and bacterial killing. , 2015, Developmental and comparative immunology.

[20]  Stephan Rosenkranz,et al.  Phosphatidylinositol 3-Kinase-dependent Membrane Recruitment of Rac-1 and p47phox Is Critical for α-Platelet-derived Growth Factor Receptor-induced Production of Reactive Oxygen Species* , 2008, Journal of Biological Chemistry.

[21]  L. Freeman Centrality in social networks conceptual clarification , 1978 .

[22]  Neil E Caporaso,et al.  Familial chronic lymphocytic leukemia , 2010, Current opinion in hematology.

[23]  F Caligaris-Cappio,et al.  B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia , 2016, Leukemia.

[24]  Edoardo Pescarmona,et al.  Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. , 1999 .

[25]  Emilio Montserrat,et al.  Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. , 1991 .

[26]  P. Chu,et al.  PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia , 2011, Leukemia.

[27]  Ayşegül Üner,et al.  Chronic lymphocytic leukemia in a child: A challenging diagnosis in pediatric oncology practice , 2014, Pediatric blood & cancer.

[28]  S. Proctor,et al.  Expression and Production of Interleukin 4 in B-Cell Chronic Lymphocytic Leukaemia , 2001, Leukemia & lymphoma.

[29]  Christian Billard,et al.  Apoptosis inducers in chronic lymphocytic leukemia , 2013, Oncotarget.

[30]  Misha Angrist,et al.  Personalized medicine and human genetic diversity. , 2014, Cold Spring Harbor perspectives in medicine.